NCT04976738View on ClinicalTrials.gov

A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

June 15, 2022

Study Completion Date

June 21, 2022

Conditions
Chronic PainNeck PainBack PainPainPain, ChronicPain, BackPain, NeckCBDTHC
Interventions
DRUG

Cybis™ 10:25 THC:CBD oil

Cybis™ 10:25 containing 10 mg/mL of D9-THC and 25 mg/mL of CBD, formulated in medium chain triglycerides (MCT)

Trial Locations (2)

2000

Holdsworth House Medical Practice, Sydney

2035

ACRN - Australian Clinical Research Network, Maroubra

Sponsors
All Listed Sponsors
lead

Cymra Life Sciences

INDUSTRY